Want to see IL:HMGS full AI Analyst Report?
Top Page
Homebiogas
(TASE:HMGS)
Select Model
Select Model
Rating:45Neutral
Price Target:
83.00
▲(7.79% Upside)
Action:Reiterated
Date:08/06/26
The score is primarily held down by weak financial performance—large ongoing losses, continued cash burn, and substantial equity erosion—despite improving revenue and gross margin. Technicals are mixed with signs of weakness/oversold conditions but no strong bullish trend confirmation. Valuation is also constrained by negative earnings and no dividend support.
Positive Factors
Revenue and gross-margin improvement
Improving revenue and gross margin indicate that the business is gaining scale and retaining more value from each sale. Although profitability remains distant, this combination can support stronger operating leverage over the next several quarters if growth and cost discipline continue.
Negative Factors
Persistent unprofitability
The company remains far from breakeven despite higher revenue and gross margin, showing that operating costs still substantially exceed its current scale. Persistent losses weaken internal capital formation and make future growth dependent on achieving much stronger operating leverage.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue and gross-margin improvement
Improving revenue and gross margin indicate that the business is gaining scale and retaining more value from each sale. Although profitability remains distant, this combination can support stronger operating leverage over the next several quarters if growth and cost discipline continue.
Read all positive factors
Homebiogas (HMGS) vs. iShares MSCI Israel ETF (EIS)
Market Cap
₪37.43M
Dividend YieldN/A
Average Volume (3M)149.28K
Price to Earnings (P/E)―
Beta (1Y)>-0.01
Revenue Growth-10.23%
EPS Growth35.34%
CountryIL
Employees71
SectorGeneral
Sector StrengthN/A
IndustryRenewable Utilities
Share Statistics
EPS (TTM)N/A
Shares Outstanding44,090,126
10 Day Avg. Volume132,263
30 Day Avg. Volume149,280
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)3.96
Price to Sales (P/S)3.54
P/FCF Ratio-4.54
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Homebiogas Business Overview & Revenue Model
Company Description
HomeBiogas LTD develops, produces, and markets innovative biogas systems that convert organic waste into clean energy. These solutions serve a broad international clientele, including private homes, agricultural businesses, commercial entities, an...
How the Company Makes Money
HomeBiogas primarily makes money by selling physical anaerobic digestion systems (and related equipment) that customers install and use to convert organic waste into usable biogas. Revenue is generated from (1) product sales of its biogas digester...
Homebiogas Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
52
Neutral
Cash Flow
22
Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.10M | 3.13M | 2.63M | 4.83M | 4.70M | 2.48M |
| Gross Profit | 1.25M | 899.53K | 384.00K | 1.55M | 1.34M | 234.00K |
| EBITDA | -4.44M | -3.76M | -8.23M | -9.91M | -14.00M | -7.64M |
| Net Income | -5.27M | -4.14M | -9.42M | -11.34M | -15.16M | -8.31M |
Balance Sheet | ||||||
| Total Assets | 5.99M | 5.23M | 8.21M | 19.43M | 19.62M | 33.58M |
| Cash, Cash Equivalents and Short-Term Investments | 2.34M | 1.95M | 2.84M | 9.14M | 11.20M | 26.05M |
| Total Debt | 340.70K | 391.08K | 470.00K | 1.95M | 1.64M | 1.99M |
| Total Liabilities | 2.96M | 2.16M | 3.23M | 5.39M | 5.23M | 5.49M |
| Stockholders Equity | 2.81M | 2.79M | 4.93M | 14.04M | 14.39M | 28.09M |
Cash Flow | ||||||
| Free Cash Flow | -3.06M | -2.44M | -5.54M | -11.13M | -12.77M | -10.72M |
| Operating Cash Flow | -3.00M | -2.43M | -4.51M | -10.58M | -11.57M | -8.33M |
| Investing Cash Flow | -10.57K | 169.95K | -847.00K | -571.00K | -1.13M | -2.49M |
| Financing Cash Flow | 2.79M | 1.02M | -639.00K | 9.28M | -419.00K | 28.77M |
Homebiogas Technical Analysis
Positive
77.00
Price Trends
84.38
Negative
71.87
Positive
88.70
Negative
Market Momentum
0.71
Negative
54.79
Neutral
70.21
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:HMGS, the sentiment is Positive. The current price of 77 is below the 20-day moving average (MA) of 77.88, below the 50-day MA of 84.38, and below the 200-day MA of 88.70, indicating a neutral trend. The MACD of 0.71 indicates Negative momentum. The RSI at 54.79 is Neutral, neither overbought nor oversold. The STOCH value of 70.21 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IL:HMGS.
Homebiogas Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
55 Neutral | ₪4.93B | -24.12 | ― | ― | 2.40% | -570.07% | |
47 Neutral | ₪4.20B | -14.73 | ― | ― | 64.06% | -1059.35% | |
46 Neutral | ₪8.13B | -64.34 | ― | ― | ― | ― | |
45 Neutral | ₪37.43M | -1.63 | ― | ― | -10.23% | 35.34% | |
44 Neutral | ₪1.91B | -34.94 | ― | ― | ― | ― |
* General Sector Average
IL:HMGS
Homebiogas
83.20
-57.60
-40.91%
IL:MSKE
Meshek Energy
1,111.00
652.60
142.36%
IL:PRIM
Prime Energy
4,000.00
2,520.00
170.27%
IL:ECNR
Econergy
6,292.00
2,372.00
60.51%
IL:SBEN
SHIKUN & BINUI ENERGY LTD
422.30
183.40
76.77%
IL:ZPRS
Zephyrus Wing Energies Ltd.
2,677.00
935.00
53.67%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.